Badgley, Phelps & Bell’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$22.1M Buy
134,208
+6,019
+5% +$996K 0.82% 39
2021
Q1
$21.1M Sell
128,189
-1,688
-1% -$273K 0.87% 39
2020
Q4
$20.4M Buy
129,877
+4,668
+4% +$689K 0.89% 39
2020
Q3
$18.6M Buy
125,209
+2,472
+2% +$366K 0.92% 38
2020
Q2
$17.3M Buy
122,737
+1,799
+1% +$262K 0.95% 34
2020
Q1
$15.9M Buy
120,938
+1,504
+1% +$213K 1.04% 29
2019
Q4
$17.4M Sell
119,434
-2,426
-2% -$329K 0.91% 39
2019
Q3
$15.8M Sell
121,860
-48,119
-28% -$6.34M 0.9% 39
2019
Q2
$23.7M Buy
169,979
+943
+0.6% +$131K 1.38% 13
2019
Q1
$23.6M Buy
169,036
+10,687
+7% +$1.43M 1.43% 13
2018
Q4
$20.4M Buy
158,349
+22,687
+17% +$3.16M 1.48% 14
2018
Q3
$18.7M Buy
135,662
+3,766
+3% +$500K 1.14% 17
2018
Q2
$16M Buy
131,896
+1,670
+1% +$208K 1.04% 23
2018
Q1
$16.7M Buy
130,226
+4,882
+4% +$660K 1.11% 18
2017
Q4
$17.5M Buy
125,344
+697
+0.6% +$97.1K 1.2% 16
2017
Q3
$16.2M Buy
124,647
+3,824
+3% +$507K 1.2% 15
2017
Q2
$16M Buy
120,823
+6
+0% +$765 1.25% 14
2017
Q1
$15M Buy
120,817
+3,903
+3% +$466K 1.22% 14
2016
Q4
$13.5M Buy
116,914
+2,057
+2% +$238K 1.17% 17
2016
Q3
$13.6M Sell
114,857
-29,720
-21% -$3.61M 1.19% 16
2016
Q2
$17.5M Buy
144,577
+870
+0.6% +$98.9K 1.6% 8
2016
Q1
$15.5M Buy
143,707
+5,254
+4% +$544K 1.46% 14
2015
Q4
$14.2M Buy
138,453
+2,729
+2% +$274K 1.4% 15
2015
Q3
$12.7M Buy
135,724
+1,687
+1% +$163K 1.32% 17
2015
Q2
$13.1M Sell
134,037
-658
-0.5% -$65.9K 1.28% 13
2015
Q1
$13.6M Sell
134,695
-1,646
-1% -$167K 1.33% 12
2014
Q4
$14.3M Sell
136,341
-183
-0.1% -$19.3K 1.4% 11
2014
Q3
$14.6M Buy
136,524
+7,089
+5% +$735K 1.44% 9
2014
Q2
$13.5M Sell
129,435
-2,310
-2% -$233K 1.35% 12
2014
Q1
$12.9M Buy
131,745
+1,155
+0.9% +$107K 1.33% 13
2013
Q4
$12M Buy
130,590
+1,538
+1% +$142K 1.26% 16
2013
Q3
$11.2M Sell
129,052
-1,988
-2% -$178K 1.26% 14
2013
Q2
$11.3M Buy
+131,040
New +$11.1M 1.32% 12

Other funds holding JNJ

Badgley, Phelps & Bell's JNJ Position: Q2 2021 in Review

Badgley, Phelps & Bell increased its Johnson & Johnson (JNJ) stake by 4.7% in Q2 2021, buying an estimated $996K and bringing the position to 134,208 shares worth $22.1M. The position accounts for 0.82% of the portfolio, ranked #39.

Badgley, Phelps & Bell first reported a position in JNJ in Q2 2013 and has held it in 33 quarters since. The position peaked at $23.7M in Q2 2019. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • Badgley, Phelps & Bell held 134,208 shares of Johnson & Johnson worth $22.1M as of Q2 2021.
  • Badgley, Phelps & Bell bought 6,019 Johnson & Johnson shares in Q2 2021, an estimated $996K.
  • Johnson & Johnson made up 0.82% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #39 holding.
  • Badgley, Phelps & Bell first reported a position in Johnson & Johnson in Q2 2013 and has held it in 33 quarters since.
  • Badgley, Phelps & Bell's Johnson & Johnson position peaked at $23.7M in Q2 2019.
  • 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.